Gland Pharma Ltd. (GLAND) Share Price Rises 5.05% Today

Gland Pharma Ltd. Share Price rises 5.05% today, reaching Rs 2,549.9 with a market cap of Rs 40,048.91 crore.

Gland Pharma Ltd. Share Price has experienced a notable increase today, rising by 5.05% to reach Rs 2,549.9. This significant price movement places the company's market capitalisation at Rs 40,048.91 crore, categorising it as a Large Cap stock.

The stock opened today at Rs 2,430 and quickly gained momentum, reaching a high of Rs 2,550. This upward movement reflects strong market sentiment and increased demand for Gland Pharma Ltd. shares. The total volume traded today was 10,21,950 shares, with a turnover of Rs 46.02 crore, suggesting robust trading activity.

While the data confirms the price rise, it does not establish a specific company-related catalyst. Investors and analysts will be keen to explore the underlying factors contributing to this price action. In the following sections, we will delve into the technical and fundamental aspects of Gland Pharma Ltd., providing a comprehensive analysis of its current position and potential implications for investors.

Gland Pharma Ltd. (GLAND) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,549.9
Previous Close	Rs 2,427.25
Today's Change	+Rs 122.65 (+5.05%)
Day Open	Rs 2,430
Day High	Rs 2,550
Day Low	Rs 2,430
Current Volume (BSE)	1,80,494
BSE Traded Volume	1,80,494
NSE Traded Volume	8,41,456
Combined NSE + BSE Volume	10,21,950
Turnover	Rs 46.02 crore
Market Capitalisation	Rs 40,048.91 crore
Market Cap Category	Large Cap

Gland Pharma Ltd. (GLAND) traded at Rs 2,549.9. versus the previous close of Rs 2,427.25, a rise of 5.05%. The stock opened at Rs 2,430, reached Rs 2,550, touched Rs 2,430. Reported volume was 1,80,494.

Gland Pharma Ltd. (GLAND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 40,048.91 crore

The healthcare sector benchmark data indicates a median P/E of 26.44 and an average P/E of 87.62, with a wide range from 3.61 to 3439.3. This suggests that the sector encompasses a diverse set of companies with varying valuations. Gland Pharma's market cap positions it among the larger entities within the sector, highlighting its significance in the industry.

While specific profitability metrics such as ROE and ROCE are not provided for Gland Pharma, the sector averages of 15.18% and 17.64%, respectively, offer a benchmark for comparison. Investors may consider these figures when evaluating Gland Pharma's financial performance relative to its peers.

In terms of cash generation, operating cash flow and free cash flow data are not available, which limits the analysis of the company's cash management efficiency. However, the company's substantial market cap and sector positioning underscore its potential for sustained growth and investor interest.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.44x
Benchmark Average P/E	87.62x
Benchmark P/E Range	3.61x to 3,439.3x
Benchmark Median P/B	1.9x
Benchmark Median ROE	11.07%
Benchmark Median ROCE	13.24%
Company Market Capitalisation	Rs 40,048.91 crore
Benchmark Median Market Cap	Rs 140.64 crore

Gland Pharma Ltd. (GLAND) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Gland Pharma Ltd. operates within the healthcare sector, which comprises 198 companies. The sector's benchmark P/E median is 26.44, with an average of 87.62, indicating a broad range of valuations. Gland Pharma's market cap of Rs 40,048.91 crore places it significantly above the sector's median market cap of Rs 140.64 crore, underscoring its prominence.

The sector's P/B median is 1.9, with an average of 2.55, reflecting the industry's asset valuation. The ROE median is 11.07%, and the ROCE median is 13.24%, providing a context for evaluating Gland Pharma's profitability metrics, which are not supplied. The healthcare sector's diverse range of companies presents various investment opportunities, with Gland Pharma positioned as a key player.

Investors should consider the sector's performance and trends when assessing Gland Pharma's potential. The company's significant market cap and sector alignment suggest a strong position within the industry, attracting attention from market participants.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,921.65	29.31	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,815.27	39.89	8.12	28.21	26.35
Hikal Ltd.	HIKAL	2,738.51	0	2.23	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,653.99	0	3.04	0	5.36
Sai Parenteral's Ltd.	SAIPARENT	2,476.69	169.37	3.13	13.9	12.97

Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 40,048.91 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Gland Pharma Ltd. competes with several notable peers in the healthcare sector. Among these, Dishman Carbogen Amcis Ltd. (DCAL) has a market cap of Rs 2,921.65 crore, with a P/E of 29.31 and a P/B of 0.43. Kwality Pharmaceuticals Ltd. (KPL) boasts a market cap of Rs 2,815.27 crore, a P/E of 39.89, and a P/B of 8.12.

Hikal Ltd. (HIKAL) has a market cap of Rs 2,738.51 crore and a P/B of 2.23, while Panacea Biotec Ltd. (PANACEABIO) has a market cap of Rs 2,653.99 crore and a P/B of 3.04. These peers provide a benchmark for evaluating Gland Pharma's market position and financial metrics.

Gland Pharma's substantial market cap of Rs 40,048.91 crore positions it well above its peers, highlighting its dominance in the sector. Investors may consider these comparisons when assessing the company's competitive standing and growth potential.

Why Investors Are Watching Gland Pharma Ltd.

Gland Pharma Ltd. has captured investor attention with its recent price rise of 5.05%, reaching Rs 2,549.9. The company's significant market cap and sector positioning make it a focal point for market participants.

• Price Action: 5.05% increase, surpassing the Large Cap threshold.
• Sector Positioning: Prominent player in the healthcare sector.
• Peer Comparison: Dominant market cap relative to peers.

Investors should monitor Gland Pharma's performance and sector trends to gauge future opportunities. The company's strong market presence and sector alignment suggest potential for continued growth and investor interest.

About Gland Pharma Ltd.

Gland Pharma Ltd. is a leading pharmaceutical company operating in the healthcare sector. The company specialises in the development, manufacturing, and marketing of complex injectables. Its product portfolio includes a wide range of therapeutic areas, catering to both domestic and international markets.

Gland Pharma's business segments encompass various pharmaceutical products, with a focus on quality and innovation. The company's strong market presence and commitment to research and development have positioned it as a key player in the industry.

With a substantial market cap of Rs 40,048.91 crore, Gland Pharma continues to expand its reach and enhance its product offerings. The company's strategic initiatives and sector alignment contribute to its growth prospects and investor appeal.

Track Gland Pharma Ltd. Share Price on Univest

Use Gland Pharma Ltd. (GLAND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Gland Pharma Ltd. Share Price on Univest to stay updated on live price movements, technical indicators, and fundamental ratios. Univest provides comprehensive insights into the company's shareholding pattern, 52-week levels, and market trends.

Stay informed with Univest's detailed analysis and market insights to make well-informed investment decisions. Explore Gland Pharma's performance and sector dynamics on Univest's platform.

Frequently Asked Questions

What is the current share price of Gland Pharma Ltd.?

Ans. The current share price of Gland Pharma Ltd. is Rs 2,549.9, reflecting a 5.05% increase from the previous close of Rs 2,427.25. The stock moved 5.05% during the session. The intraday range extended from Rs 2,430 to Rs 2,550.

How much did Gland Pharma Ltd.'s share price rise today?

Ans. Gland Pharma Ltd.'s share price rose by 5.05% today, marking a significant gain in the stock's value. The stock moved 5.05% during the session. The intraday range extended from Rs 2,430 to Rs 2,550.

How does Gland Pharma Ltd.'s market cap compare to its peers?

Ans. Gland Pharma Ltd.'s market cap of Rs 40,048.91 crore is significantly higher than its peers, highlighting its dominance in the sector. The company operates in the Healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal.

What is the sector benchmark P/E for healthcare?

Ans. The sector benchmark P/E for healthcare has a median of 26.44 and an average of 87.62, reflecting a diverse range of valuations. The relevant peer median P/E is 26.44x. The peer average P/E is 87.62x.

Who are Gland Pharma Ltd.'s main competitors?

Ans. Gland Pharma Ltd.'s main competitors include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd., among others. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.

How can I track Gland Pharma Ltd.'s share price?

Ans. You can track Gland Pharma Ltd.'s share price on Univest for live updates, technical indicators, and comprehensive market insights. The stock moved 5.05% during the session. The intraday range extended from Rs 2,430 to Rs 2,550.